Combo of old drugs offers new hope in obesity fight - CNN.comDiet drugs have had a rough year in 2010. In October, the U.S. Food and Drug Administration (FDA) nixed not one but two new weight-loss drugs, lorcaserin and Qnexa, because of possible links to cancer (lorcaserin) and heart problems (Qnexa).
But this week an FDA advisory committee gave the thumbs up to a third drug, Contrave, meaning there could be a new tool on the horizon for battling obesity.
(The FDA doesn't have to approve the drug, but often follows its panels' advice.)
And really, doctors could use one. Previous attempts to find safe diet drugs that work by controlling appetite have met with some success, but most have been doomed by side effects.
Fen-phen, heavily marketed in the 1990s, caused heart valve problems while rimonabant became linked with suicidal thinking and depression, leading an FDA advisory committee to recommend against approving it in 2007.
Really simple topic here --> Since study after study after study has shown that obesity is almost entirely linked with caloric intake vs. caloric output, in typical people, (basically, diet vs. exercise - I cite the recent Twinkie Diet experiment, for example) is it ethical to treat obesity using heavy drugs, or make/allow people to think that obesity can be managed using heavy drugs?